BA Lynch, N Lambeng, K Nocka… - Proceedings of the …, 2004 - National Acad Sciences
Here, we show that the synaptic vesicle protein SV2A is the brain binding site of
levetiracetam (LEV), a new antiepileptic drug with a unique activity profile in animal models …